Using Trademarks to Ensure Completion of Postapproval Trials

Bibliographic Data

ID15809013
AuthorsCatherine S Hwang (0009-0004-0185-3256, VA Portland Health Care System), S Sean Tu (0000-0003-0391-8186, West Virginia University, corresponding author)
Year2025
Volume6
Issue2
Pagese250001-e250001
Publication date2025-02-28
Open AccessYes
TypeARTICLE
VenueJAMA Health Forum (JOURNAL)
Journal identifiersISSN: 2689-0186 • E-ISSN: 2689-0186
PublisherAmerican Medical Association (PUBLISHER • US)
DOI10.1001/jamahealthforum.2025.0001
PMID40019740
OpenAlexW4408052194
LanguageEN
References cited7

This Viewpoint evaluates how using trademarks can support the US Food and Drug Administration’s mission to approve safe and effective medications

Administration (probate law · Business · Food and drug administration · Political science · Risk analysis (engineering · Biomedical Ethics and Regulation · Health Systems, Economic Evaluations, Quality of Life · Law · Science, Research, and Medicine

Tools

Open DOIOpen Access